IRWD
IRONWOOD PHARMACEUTICALS INCCompany Information
- Company Name
- IRONWOOD PHARMACEUTICALS INC
- CIK
- CIK0001446847
- Category
- Accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- IRWD: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- IRWD
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-03-06
- Last sale
- 2026-07-07
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 7,109,782
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 155,511,097
- Shares outstanding
- 164,405,000
- Ownership
- 94.59%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- -3.05%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 79 | 220 | 215 | 140 | 93 | 108 | 89 | 88 | 106 | 122 | 92 | 110 | ||||||
| Accounts Receivable Net Current | 113 | 106 | 47 | 120 | 86 | 40 | 82 | 76 | 58 | 72 | 129 | 125 | ||||||
| Prepaid Expense And Other Assets Current | 7 | 6 | 12 | 13 | 13 | 12 | 12 | 14 | 15 | 15 | 12 | 18 | ||||||
| Restricted Cash Current | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Assets Current | 199 | 332 | 274 | 274 | 192 | 161 | 182 | 179 | 178 | 208 | 233 | 254 | ||||||
| Restricted Cash Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Property Plant And Equipment Net | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 6 | 6 | ||||||
| Operating Lease Right Of Use Asset | 8 | 9 | 9 | 10 | 10 | 11 | 11 | 11 | 12 | 12 | 13 | 13 | ||||||
| Finite Lived Intangible Assets Net | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | ||||||
| Deferred Income Tax Assets Net | 69 | 84 | 103 | 102 | 129 | 144 | 144 | 185 | 193 | 206 | 212 | 244 | ||||||
| Other Assets Noncurrent | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 6 | 4 | 3 | 4 | 4 | ||||||
| Assets | 285 | 435 | 397 | 396 | 343 | 327 | 351 | 390 | 396 | 439 | 471 | 524 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 3 | 3 | 2 | 1 | 6 | 2 | 3 | 3 | 6 | 8 | 5 | ||||||
| Operating Lease Liability Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Convertible Debt Current | - | 200 | 200 | 200 | 199 | - | - | - | - | 200 | 200 | 199 | ||||||
| Liabilities Current | 33 | 236 | 242 | 243 | 233 | 48 | 39 | 49 | 46 | 252 | 276 | 281 | ||||||
| Convertible Debt Noncurrent | - | - | - | - | - | 199 | 199 | 199 | 199 | 198 | 198 | 198 | ||||||
| Operating Lease Liability Noncurrent | 9 | 9 | 10 | 10 | 11 | 12 | 12 | 13 | 13 | 14 | 15 | 15 | ||||||
| Long Term Line Of Credit | 385 | 385 | 385 | 385 | 385 | 385 | 385 | 400 | 425 | 275 | 300 | 325 | ||||||
| Other Liabilities Noncurrent | 21 | 21 | 22 | 22 | 22 | 17 | 17 | 40 | 35 | 29 | 28 | 31 | ||||||
| Liabilities | 447 | - | - | - | - | - | - | - | - | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,420 | 1,416 | 1,413 | 1,409 | 1,405 | 1,401 | 1,395 | 1,391 | 1,382 | 1,373 | 1,355 | 1,375 | ||||||
| Retained Earnings Accumulated Deficit | -1,582 | -1,633 | -1,674 | -1,671 | -1,712 | -1,735 | -1,698 | -1,700 | -1,704 | -1,703 | -1,699 | -1,698 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -1 | -1 | -2 | -2 | 0 | 1 | -2 | -0 | -1 | -3 | -1 | ||||||
| Stockholders Equity | -162 | -217 | -262 | -264 | -308 | -334 | -301 | -311 | -322 | -331 | -346 | -326 | ||||||
| Minority Interest | - | - | - | - | - | - | - | - | - | - | - | -2 | ||||||
| Liabilities And Stockholders Equity | 285 | 435 | 397 | 396 | 343 | 327 | 351 | 390 | 396 | 439 | 471 | 524 | ||||||
Preferred Stock Number Of Shares Par Value And Other Disclosures | ||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Common Stock Number Of Shares Par Value And Other Disclosures | ||||||||||||||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 165 | 165 | 163 | 163 | 162 | 162 | 160 | 160 | 160 | 159 | 156 | 156 | ||||||
| Shares Outstanding | 165 | 165 | 163 | 163 | 162 | 162 | 160 | 160 | 160 | 159 | 156 | 156 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialIRONWOOD PHARMACEUTICALS INC (IRWD) — SEC Financial Statements & Analysis
IRONWOOD PHARMACEUTICALS INC (IRWD) is a pharmaceutical preparations company, incorporated in DE. IRONWOOD PHARMACEUTICALS INC trades on Nasdaq as: IRWD. IRONWOOD PHARMACEUTICALS INC (IRWD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, IRONWOOD PHARMACEUTICALS INC carries a market cap of $692.15M, a P/E ratio of 5.33x, a P/B ratio of -4.28x, a P/S ratio of 1.78x, an enterprise value of $613.02M, and an EV/EBITDA multiple of 2.60x. On profitability, it posts a gross margin of 106.61%, an operating margin of 60.15%, a net margin of 33.36%, a Return on Equity (ROE) of -55.26%, and a Return on Assets (ROA) of 41.35%. Per share, it reports EPS of $0.79, diluted EPS of $0.78, free cash flow per share of $1.13, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 26.19% year-over-year, net income growth of -1747.03% year-over-year, and EPS growth of -1720.16% year-over-year. On the balance sheet, it maintains a current ratio of 6.06x, a quick ratio of 5.84x, working capital of $166.35M, a debt-to-equity ratio of -2.76x, a debt ratio of 1.57, an interest coverage ratio of 7.17x, free cash flow of $185.52M (TTM), and net debt of $-79.13M. Figures sourced from SEC EDGAR.
- Market Cap
- $692.15M
- P/E TTM
- 5.33x
- EPS TTM
- $0.79
- P/B TTM
- -4.28x
- ROE TTM
- -55.26%
- ROA TTM
- 41.35%
- Debt To Equity
- -2.76x
- Free Cash Flow TTM
- $185.52M
- Net Revenue TTM Growth 1Y
- 26.19%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is IRONWOOD PHARMACEUTICALS INC in?
IRONWOOD PHARMACEUTICALS INC (IRWD) operates in the Pharmaceutical Preparations industry.
What exchange does IRWD trade on?
IRONWOOD PHARMACEUTICALS INC (IRWD) trades on the Nasdaq.
Where is IRONWOOD PHARMACEUTICALS INC incorporated?
IRONWOOD PHARMACEUTICALS INC is incorporated in DE.
When was IRONWOOD PHARMACEUTICALS INC (IRWD)'s most recent SEC filing?
IRONWOOD PHARMACEUTICALS INC (IRWD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is IRWD's market cap?
IRONWOOD PHARMACEUTICALS INC (IRWD) has a market capitalization of $692.15M as of 2026-06-30.
What is IRWD's P/E ratio?
IRONWOOD PHARMACEUTICALS INC (IRWD)'s trailing twelve month P/E ratio is 5.33x as of 2026-06-30.
What is IRWD's EPS (earnings per share)?
IRONWOOD PHARMACEUTICALS INC (IRWD)'s trailing twelve month EPS is $0.79 as of 2026-06-30.
What is IRWD's ROE (return on equity)?
IRONWOOD PHARMACEUTICALS INC (IRWD)'s trailing twelve month Return on Equity (ROE) is -55.26% as of 2026-06-30.
What is IRWD's ROA (return on assets)?
IRONWOOD PHARMACEUTICALS INC (IRWD)'s trailing twelve month Return on Assets (ROA) is 41.35% as of 2026-06-30.
What is IRWD's EV/EBITDA?
IRONWOOD PHARMACEUTICALS INC (IRWD)'s trailing twelve month EV/EBITDA is 2.60x as of 2026-06-30.